
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
What is a Trump Gold Card? U.S. launches $1 million immigration visas - 2
Figure out How to Back Your Rooftop Substitution - 3
Shah Capital pushes for Novavax sale, warns of proxy fight - 4
Novo Nordisk gears up for December Ozempic launch in India, sources say - 5
Chicago reports first rabies-positive dog in 61 years. What we know.
Which Film Has the Incomparable Melodic Score?
Top 10 Arising Advances That Will Shape What's in store
Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
Minneapolis ICE shooting: Woman dies after federal agent opens fire on her vehicle amid immigration crackdown
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
The Ascent of Rousing Pioneers Who Formed History
The most exciting exoplanet discoveries of 2025
Step by step instructions to Protect Your Senior Condo for Ideal Wellbeing and Solace













